1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD)

MLA

Christie M. Ballantyne, et al. “1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD).” Diabetes, vol. 69, June 2020. EBSCOhost, https://doi.org/10.2337/db20-1429-p.

APA

Christie M. Ballantyne, Shushama Alam, Yuyin Liu, Mikhail Kosiborod, Mary Jane Elliott, Deepak L. Bhatt, Robert S. Rosenson, James A. de Lemos, Katherine E Mues, Christopher P. Cannon, & Kiran Philip. (2020). 1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD). Diabetes, 69. https://doi.org/10.2337/db20-1429-p

Chicago

Christie M. Ballantyne, Shushama Alam, Yuyin Liu, Mikhail Kosiborod, Mary Jane Elliott, Deepak L. Bhatt, Robert S. Rosenson, et al. 2020. “1429-P: Use of Guideline-Recommended Risk-Reduction Strategies among Patients with Type 2 Diabetes and Established ASCVD: A 1-Year Update from Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD).” Diabetes 69 (June). doi:10.2337/db20-1429-p.